Uncompensated care costs have been a pressing issue for hospitals in states that opted out of Medicaid expansion.

On the whole, companies are in better shape today than at this time in 2020.

Johnson & Johnson is following in the footsteps of other big drugmakers that have moved to focus on the more-profitable pharmaceutical market.

What do brokers need to know when discussing this important service capability with employers?